These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 28618942)
21. Prognostic role of DEK in human solid tumors: a meta-analysis. Liu G; Xiong D; Zeng J; Xu G; Xiao R; Chen B; Huang Z Oncotarget; 2017 Nov; 8(58):98985-98992. PubMed ID: 29228743 [TBL] [Abstract][Full Text] [Related]
22. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis. Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926 [TBL] [Abstract][Full Text] [Related]
23. The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis. Qian H; Appiah-Kubi K; Wang Y; Wu M; Tao Y; Wu Y; Chen Y Crit Rev Oncol Hematol; 2018 Jul; 127():15-28. PubMed ID: 29891108 [TBL] [Abstract][Full Text] [Related]
24. TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis. Zeng P; Zhang P; Zhou LN; Tang M; Shen YX; Jin J; Zhu YQ; Chen MB Oncotarget; 2016 Nov; 7(46):76327-76336. PubMed ID: 27344186 [TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Park H; Lee Y; Lee H; Kim JW; Hwang JH; Kim J; Yoon YS; Han HS; Kim H Tumour Biol; 2017 Oct; 39(10):1010428317718403. PubMed ID: 29025374 [TBL] [Abstract][Full Text] [Related]
26. TIM-3 is a potential prognostic marker for patients with solid tumors: A systematic review and meta-analysis. Zhang Y; Cai P; Liang T; Wang L; Hu L Oncotarget; 2017 May; 8(19):31705-31713. PubMed ID: 28423646 [TBL] [Abstract][Full Text] [Related]
27. PD-L1 and Survival in Solid Tumors: A Meta-Analysis. Wu P; Wu D; Li L; Chai Y; Huang J PLoS One; 2015; 10(6):e0131403. PubMed ID: 26114883 [TBL] [Abstract][Full Text] [Related]
28. p21-activated kinase 1 (PAK1) expression correlates with prognosis in solid tumors: A systematic review and meta-analysis. Fang F; Pan J; Li YP; Li G; Xu LX; Su GH; Li ZH; Feng X; Wang J Oncotarget; 2016 May; 7(19):27422-9. PubMed ID: 27027431 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of PIVKA-II in hepatocellular carcinoma patients receiving curative ablation: A systematic review and meta-analysis. Zhang D; Liu Z; Yin X; Qi X; Lu B; Liu Y; Hou J Int J Biol Markers; 2018 Aug; 33(3):266-274. PubMed ID: 29658364 [TBL] [Abstract][Full Text] [Related]
30. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis. Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202 [TBL] [Abstract][Full Text] [Related]
31. HER3 overexpression and survival in solid tumors: a meta-analysis. Ocana A; Vera-Badillo F; Seruga B; Templeton A; Pandiella A; Amir E J Natl Cancer Inst; 2013 Feb; 105(4):266-73. PubMed ID: 23221996 [TBL] [Abstract][Full Text] [Related]
32. The role of SOX2 overexpression in prognosis of patients with solid tumors: A meta-analysis and system review. Wang S; Liu X; Chen Y; Zhan X; Wu T; Chen B; Sun G; Yan S; Xu L Medicine (Baltimore); 2020 Mar; 99(13):e19604. PubMed ID: 32221082 [TBL] [Abstract][Full Text] [Related]
33. Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer. Inokuchi M; Murase H; Otsuki S; Kawano T; Kojima K World J Surg Oncol; 2017 Jan; 15(1):2. PubMed ID: 28056982 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of Fibroblast Growth Factor Receptor 2 Expression, Heterogeneity and Clinical Significance in Gastric Cancer. Han N; Kim MA; Lee HS; Kim WH Pathobiology; 2015; 82(6):269-79. PubMed ID: 26516773 [TBL] [Abstract][Full Text] [Related]
35. LDH5 overexpression is associated with poor survival in patients with solid tumors: a meta-analysis. Yao Y; Wang H; Li B Tumour Biol; 2014 Jul; 35(7):6973-81. PubMed ID: 24744144 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis. Zeng P; Li H; Lu PH; Zhou LN; Tang M; Liu CY; Chen MB Sci Rep; 2017 Jun; 7(1):4223. PubMed ID: 28652617 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis. Yang SL; Ren QG; Wen L; Hu JL J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798 [TBL] [Abstract][Full Text] [Related]
38. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy. Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348 [TBL] [Abstract][Full Text] [Related]
39. Prognostic and clinicopathological role of long non-coding RNA UCA1 in various carcinomas. Wang X; Peng F; Cheng L; Yang G; Zhang D; Liu J; Chen X; Zhao S Oncotarget; 2017 Apr; 8(17):28373-28384. PubMed ID: 28423704 [TBL] [Abstract][Full Text] [Related]
40. The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis. Li JZ; Gao W; Ho WK; Lei WB; Wei WI; Chan JY; Wong TS Chin J Cancer; 2016 Nov; 35(1):95. PubMed ID: 27852288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]